NCT04284865 is a NA clinical trial of Web Platform in COPD, sponsored by Université de Sherbrooke.

Who is sponsoring NCT04284865?

NCT04284865 is sponsored by Université de Sherbrooke.

What drugs are being tested in NCT04284865?

Interventions in NCT04284865: Web Platform.

Is NCT04284865 still recruiting?

NCT04284865 is currently completed. Last updated 14 January 2025.

Last reviewed 2025-01-14 · How we verify

NCT04284865

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Optimizing Maintenance for Patients with COPD Via a Web Platform - Case Study

Completed NA Last updated 14 January 2025

What this trial tests

NA trial testing Web Platform in COPD in 3 participants. Completed in 31 December 2021.

Timeline

1 November 2020

Primary endpoint
1 November 2021

31 December 2021

Quick facts

Lead sponsor	Université de Sherbrooke
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	3
Start date	1 November 2020
Primary completion	1 November 2021
Estimated completion	31 December 2021
Sites	1 location across Canada

Drugs / interventions tested

Web Platform

Conditions studied

COPD — all drugs for COPD →

Sponsor

Université de Sherbrooke — full company profile →

Who can join

18 and older, any sex, with COPD. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Pulmonary rehabilitation (PR) has been shown to improve quality of life of people with COPD by decreasing their symptoms. However, the benefits obtained during PR tend to decrease within six months to one year after PR. The objective of this study is to implement a web platform following PR programs in order to improve COPD patients' adherence to self-management techniques. Therefore, the investigators want to verify whether the addition of a tele-management tool allows the gains obtained during PR to be retained over 3, 6 and 12 months. The hypothesis is that participants will maintain their PR gains if they use the platform.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Telerehabilitation for chronic respiratory disease.
Cox NS, Dal Corso S, Hansen H, McDonald CF, et al · · 2021 · cited 280× · PMID 33511633 · DOI 10.1002/14651858.cd013040.pub2
Supervised maintenance programmes following pulmonary rehabilitation compared to usual care for chronic obstructive pulmonary disease.
Malaguti C, Dal Corso S, Janjua S, Holland AE. · · 2021 · cited 38× · PMID 34404111 · DOI 10.1002/14651858.cd013569.pub2

Verify or expand the search:

Other recruiting trials for COPD

Currently open trials in the same condition.

NCT07344649 — Turkish Validation of the Nijmegen Questionnaire in COPD · recruiting
NCT07524023 — Emotional-distress-based Integrated Care Programme in Patients With Stable COPD · NA · recruiting
NCT07460154 — Structured Review: To Optimise Management and Prevent Harm in COPD · NA · recruiting
NCT07462221 — Effect of Telenursing on Oral Health · NA · recruiting
NCT07051707 — Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD · NA · recruiting

Other Université de Sherbrooke trials

Trials by the same sponsor.

NCT07524764 — Female Reproductive Health in Canadian Armed Forces · not yet recruiting
NCT07511842 — REST-Knee: A Pilot RCT of 72-Hour Knee Immobilization and Pain Outcomes · NA · recruiting
NCT07360587 — Thyroid Artery Embolization for the Treatment of Compressive Goiters. · NA · recruiting
NCT07396857 — The Role of EDHFs on Blood Pressure Following a Bout of Prolonged Sitting · NA · recruiting
NCT07122531 — Recovery With Exogenous Ketones and Antipsychotics · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04284865 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Université de Sherbrooke
Last refreshed: 14 January 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04284865.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing